Related Experiment Video
Updated: Aug 30, 2025

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
COVID-19-Induced Myopericarditis Leading to Cardiac Tamponade: An Unusual Case Presentation
Niel Shah1, Mohamed Saleh2, Abhilasha Jyala3
1Internal Medicine, Einstein Medical Center Philadelphia, Philadelphia, USA.
Insights
Coronavirus disease 2019 (COVID-19) can cause cardiac issues like myopericarditis, even with mild respiratory symptoms. This case highlights severe cardiac complications, including cardiac tamponade, in a COVID-19 patient.
Area of Science:
- Cardiology
- Infectious Diseases
- Internal Medicine
Background:
- Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations, from asymptomatic infection to severe respiratory distress.
- Cardiac involvement is a recognized complication of COVID-19, occurring independently of respiratory symptoms.
- Common cardiac manifestations include heart failure, myopericarditis, and arrhythmias, with troponin elevation linked to increased mortality.
Observation:
- COVID-19 can induce pericardial inflammation through direct viral effects or immune responses, though mechanisms remain under investigation.
- This case involves a patient with COVID-19 who developed myopericarditis.
- The myopericarditis was complicated by pericardial effusion and cardiac tamponade.
Findings:
- The patient presented with minimal pulmonary involvement, underscoring that cardiac complications can be primary or dominant features of COVID-19.
- Myopericarditis, pericardial effusion, and cardiac tamponade were observed in this COVID-19 case.
- Distinguishing COVID-19-related cardiac injury from heart failure can be clinically challenging.
Implications:
- This case emphasizes the critical need for cardiac monitoring in COVID-19 patients, even those with limited respiratory symptoms.
- Understanding the mechanisms of COVID-19-induced cardiac inflammation is crucial for developing targeted therapies.
- Early recognition and management of cardiac complications like tamponade are vital for improving outcomes in COVID-19 patients.
Abstract:
Coronavirus disease 2019 (COVID-19) can manifest differently in different patients, ranging from asymptomatic carriers to acute respiratory distress syndrome (ARDS). Cardiac involvement may occur with COVID-19 even without respiratory tract signs and symptoms of infection. Cardiac manifestations like heart failure (HF), myopericarditis, and cardiac arrhythmias are commonly reported. Cardiac injury with troponin leak is associated with increased mortality in COVID-19, and its clinical and radiographic features are difficult to distinguish from those of HF. COVID-19 is also known to cause pericardial inflammation, likely via direct cytotoxic effects or immune-mediated mechanisms. However, the definite mechanism is still unclear. We present here a case of myopericarditis complicated by pericardial effusion and cardiac tamponade in a COVID-19 infected patient with minimal pulmonary involvement.
Related Concept Videos
Pericarditis III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis IV: Nursing Management
Pericarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis I: Introduction

